Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired March 28, 2021, on "Face the Nation."
Food and Drug Administration
AstraZeneca's COVID-19 vaccine study
Drugmaker AstraZeneca is preparing to request emergency use authorization for its coronavirus vaccine in the U.S. after its latest clinical trial finds the vaccine was fully effective in preventing COVID-19 hospitalizations and 79% effective in stopping symptomatic illness. Dr. Alonzo Plough, chief science officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the potential impact in the fight against the pandemic.
Gottlieb warns of threat from troubling New York virus variant
Dr. Scott Gottlieb, the former FDA commissioner, says health officials need to do more to understand whether the B.1.526 virus variant is infecting those who have already had COVID-19 or have been vaccinated.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired March 21, 2021, on "Face the Nation."
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired March 14, 2021, on "Face the Nation."
Gottlieb: Variant may cause infections to "tick back up"
Dr. Scott Gottlieb, the former FDA commissioner, says the variant first detected in the U.K. "will probably cause infections to tick back up," but doesn't predict a surge.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired March 7, 2021, on "Face the Nation."
Homemade baby formula can be life-threatening, FDA says
Food regulators warn that DIY baby formula can lead to nutritional imbalances and foodborne illness.
Doctor says get whatever vaccine is available
Americans now have a third coronavirus vaccine option after Johnson & Johnson received emergency-use authorization from the Food and Drug Administration for its single-dose shot. The company wants to distribute 20 million doses by the end of March. Dr. Ron Elfenbein, the medical director and owner of First Call Medical Center, joined CBSN to discuss.
Johnson & Johnson one-shot COVID vaccine rolls out in the U.S.
The vaccine is the third to roll out for use in the United States, and the first that requires only one shot.
Johnson & Johnson ships COVID-19 vaccine
Johnson & Johnson has begun shipping its single-dose COVID-19 vaccine, the third jab to become available in the United States as the country races to get Americans inoculated. Dr. Rick Nettles, the vice president of medical affairs for Janssen Infectious Diseases and Vaccines at Johnson & Johnson, joins CBSN to answer questions about the company's vaccine.
Johnson & Johnson begins shipping vaccine
The new single-dose vaccine began shipping out Monday morning after the FDA issued emergency use authorization for the shot. It is the third COVID-19 vaccine to become available in the United States. CBS News' Debra Alfarone joins CBSN AM to discuss.
Johnson & Johnson CEO touts "ease" of single-shot vaccine distribution
Four million doses are being shipped out Monday of the newly-approved coronavirus vaccination, with 100 million promised by the end of June.
Is the one-shot method better than the two-shot method?
Which vaccine is the most effective against the coronavirus? The Moderna and Pfizer vaccines require two shots to be fully vaccinated. However, the new Johnson and Johnson vaccine uses a one-shot method and is easier to store. CBS News researcher Max Bayer joins CBSN's Land Zak to discuss the difference between the vaccines, their efficacy against variants, and if pregnant women should be vaccinated.
FDA approves one-shot vaccine
On Saturday, the FDA approved the one-shot Johnson & Johnson COVID-19 vaccine. The race to vaccinate is picking up as new variants have been identified. Danya Bacchus reports.
FDA panel OKs Johnson & Johnson COVID-19 vaccine
An FDA advisory panel voted Friday in favor of Johnson & Johnson's coronavirus vaccine. If the FDA gives the final approval, millions of doses could ship out as early as this weekend. The news comes as the CDC warns declines in cases and hospitalizations may be stalling. Dr. Dara Kass, and ER doctor and medical contributor for Yahoo News, joins CBSN to discuss the latest in the fight against COVID-19.
FDA: Johnson & Johnson vaccine works well
An FDA review released today confirms the single-dose Johnson & Johnson vaccine is both safe and effective against COVID-19, likely setting the stage for a third vaccine to be authorized for use in the U.S. Dr. Neeta Ogden joins CBSN with more.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired February 28, 2021, on "Face the Nation."
Open: This is "Face the Nation," February 28
Today on "Face the Nation," the U.S. hits two devastating benchmarks -- half a million dead and one year since the first reported coronavirus death -- but there is hope on the horizon.
Oxford researchers attempt to battle variants
Researchers at Oxford-AstraZeneca are working on a more effective shot to tackle new coronavirus variants. The testing comes as the company conducts U.S. trials to present for FDA approval. CBS News foreign correspondent Charlie D'Agata reports.
How the Johnson & Johnson vaccine compares
Doctor Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security at the Bloomberg School of Public Health, joins "CBS This Morning: Saturday" to discuss how the Johnson & Johnson vaccine compares to others.
12/17: Red and Blue
Congress inching closer to stimulus relief deal; Losing the fight to unseat Sen. Susan Collins
12/8: Red and Blue
The 'safe harbor' deadline to certify results; Voting underway in crucial Georgia Senate races
Johnson & Johnson's single-dose vaccine is effective, FDA says
FDA scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19, and even better at preventing hospitalizations and deaths.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired February 21, 2021, on "Face the Nation."
Trump promised to lower prices for Americans. Here's what the data shows.
Hurricane Isaias now a Category 3 storm as it threatens northern Gulf Coast
Interactive
These documents tell the story of the Cornell rape allegations
Pentagon's plan to livestream execution sparks intense backlash
Live
Iran's Houthi allies step up deadly attacks on Saudi Arabia
NYPD body camera footage shows aftermath of ICE agent shooting
Trump creates committee to investigate Fed's Lisa Cook
Nobel Peace Prize awarded to former ICC judge Navi Pillay
